DD
Therapeutic Areas
Biosyngen Pipeline
| Drug | Indication | Phase |
|---|---|---|
| BRG01 | Nasopharyngeal carcinoma (EBV+) | Phase 2 |
| BST02 | Liver cancer (all types) | Phase 1 |
| BGT007 | Dual CAR‑T for solid tumors | Investigator‑initiated trial |
| ALLO‑CEL | Multiple solid & liquid tumors (allogeneic) | Pre‑clinical / IND filing |
| GGT008 | Colorectal, gastric, esophageal, pancreatic cancers | Pre‑clinical |